Mark A Rubin

Zitiert von

	Alle	Seit 2019
Zitate	158146	82564
h-index	182	121
i10-index	561	437

16000

8000

4000

12000

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024537 902 1421 1577 2035 2559 3480 3354 4160 4716 5531 6327 6479 6422 7244 7748 9019 11280 13813 15848 15194 13736 12640

Öffentlicher Zugriff

Alle anzeigen

317 Artikel

10 Artikel

verfügbar

nicht verfügbar

Basierend auf Fördermandaten

Koautoren

Francesca DemichelisDepartment of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, ItalyBestätigte E-Mail-Adresse bei unitn.it
Andrea SbonerAssociate Professor, Department of Pathology and Laboratory Medicine, EIPM, WCMBestätigte E-Mail-Adresse bei med.cornell.edu
Scott TomlinsAssociate Professor of Pathology and UrologyBestätigte E-Mail-Adresse bei umich.edu
Kenneth PientaProfessor of Urology, Oncology, Pharmacology and Molecular Sciences, Johns Hopkins UniversityBestätigte E-Mail-Adresse bei jhmi.edu
Martin G SandaProfessor and Chairman of Urology, Emory University School of MedicineBestätigte E-Mail-Adresse bei emory.edu
Olivier ElementoDirector, Englander Institute for Precision Medicine, Weill Cornell MedicineBestätigte E-Mail-Adresse bei med.cornell.edu
Christopher BarbieriAssociate Professor of Urology, Weill Cornell MedicineBestätigte E-Mail-Adresse bei med.cornell.edu
Daniel RhodesUniversity of Michigan, Compendia Bioscience, Life TechnologiesBestätigte E-Mail-Adresse bei lifetech.com
Debashis GhoshProfessor, Colorado School of Public HealthBestätigte E-Mail-Adresse bei ucdenver.edu
Ronglai ShenMemorial Sloan-Kettering Cancer CenterBestätigte E-Mail-Adresse bei mskcc.org
Mark GersteinProfessor of Biomedical Informatics, Yale UniversityBestätigte E-Mail-Adresse bei yale.edu
Rameen BeroukhimDana-Farber Cancer Institute, Harvard Medical SchoolBestätigte E-Mail-Adresse bei broadinstitute.org
Brian D. Robinson, M.D.Professor of Pathology and Urology, Weill Cornell Medical CollegeBestätigte E-Mail-Adresse bei med.cornell.edu
Martin GleaveProfessor of Urologic Sciences, University of British ColumbiaBestätigte E-Mail-Adresse bei ubc.ca
Abhishek SrivastavaFox Chase Cancer CenterBestätigte E-Mail-Adresse bei fccc.edu
Angelo M. De Marzo M.D., Ph.D.Professor of Pathology, Urology and Oncology, The Johns Hopkins University School of MedicineBestätigte E-Mail-Adresse bei jhmi.edu
Chandan Kumar-SinhaUniversity of MichiganBestätigte E-Mail-Adresse bei umich.edu
David RimmYale UniversityBestätigte E-Mail-Adresse bei yale.edu
Barbara WeirPrincipal Scientist, Janssen R&DBestätigte E-Mail-Adresse bei its.jnj.com
Cheng LiPrincipal Investigator, School of Life Sciences, Peking University, Beijing, ChinaBestätigte E-Mail-Adresse bei pku.edu.cn

Folgen

Mark A Rubin

Professor & Director Department for BioMedical Research, University of Bern

Bestätigte E-Mail-Adresse bei dbmr.unibe.ch - Startseite

Cancer genomics


Titel Nach Zitationen sortieren Nach Jahr sortieren Nach Titel sortieren	Zitiert von Zitiert von	Jahr
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ... science 310 (5748), 644-648, 2005	4877	2005
The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018	4866	2018
The landscape of somatic copy-number alteration across human cancers R Beroukhim, CH Mermel, D Porter, G Wei, S Raychaudhuri, J Donovan, ... Nature 463 (7283), 899-905, 2010	4444	2010
Integrative clinical genomics of advanced prostate cancer D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ... Cell 161 (5), 1215-1228, 2015	3893	2015
The polycomb group protein EZH2 is involved in progression of prostate cancer S Varambally, SM Dhanasekaran, M Zhou, TR Barrette, C Kumar-Sinha, ... Nature 419 (6907), 624-629, 2002	3342	2002
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018	2942	2018
The molecular taxonomy of primary prostate cancer A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ... Cell 163 (4), 1011-1025, 2015	2764	2015
Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018	2747	2018
DNA-repair defects and olaparib in metastatic prostate cancer J Mateo, S Carreira, S Sandhu, S Miranda, H Mossop, R Perez-Lopez, ... New England Journal of Medicine 373 (18), 1697-1708, 2015	2383	2015
Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018	2351	2018
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing GM Frampton, A Fichtenholtz, GA Otto, K Wang, SR Downing, J He, ... Nature biotechnology 31 (11), 1023-1031, 2013	2270	2013
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ... Cell 173 (2), 291-304. e6, 2018	2207	2018
Delineation of prognostic biomarkers in prostate cancer SM Dhanasekaran, TR Barrette, D Ghosh, R Shah, S Varambally, ... Nature 412 (6849), 822-826, 2001	2151	2001
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells CG Kleer, Q Cao, S Varambally, R Shen, I Ota, SA Tomlins, D Ghosh, ... Proceedings of the national academy of sciences 100 (20), 11606-11611, 2003	2025	2003
Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020	1936*	2020
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma LA Garraway, HR Widlund, MA Rubin, G Getz, AJ Berger, S Ramaswamy, ... Nature 436 (7047), 117-122, 2005	1816	2005
Machine learning identifies stemness features associated with oncogenic dedifferentiation TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ... Cell 173 (2), 338-354. e15, 2018	1787	2018
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer CE Barbieri, SC Baca, MS Lawrence, F Demichelis, M Blattner, ... Nature genetics 44 (6), 685-689, 2012	1776	2012
Inherited DNA-repair gene mutations in men with metastatic prostate cancer CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, ... New England Journal of Medicine 375 (5), 443-453, 2016	1726	2016
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer H Beltran, D Prandi, JM Mosquera, M Benelli, L Puca, J Cyrta, C Marotz, ... Nature medicine 22 (3), 298-305, 2016	1567	2016

Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.

Artikel 1–20

Zitate pro Jahr

Doppelte Zitate

Zusammengeführte Zitate

Koautor hinzufügenKoautoren

Folgen

Zitiert von

Koautoren